tiprankstipranks
Arca Biopharma (ABIO)
NASDAQ:ABIO

Arca Biopharma (ABIO) Ownership - Who Owns Arca Biopharma?

461 Followers

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Bought$2397243

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,221,465Insider70.46%38,023,850
10,221,465Insider70.46%38,023,850
2,100,000Insider14.48%7,812,000
1,410,143Institution9.72%5,245,732
491,889Insider3.39%1,829,827
453,598Institution3.13%1,687,385
453,598Institution3.13%1,687,385
134,831Institution0.93%501,571
50,970Insider0.35%189,608
50,000Insider0.34%186,000

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
453,598Institution3.13%1,687,385
134,831Institution0.93%501,571
46,948Institution0.32%174,647
32,400Institution0.22%120,528
14,988Institution0.10%55,755
3,161Institution0.02%11,759
174Institution<0.01%647

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
312,166Institution2.15%1,089,459
141,432Institution0.97%493,598
5,162Institution0.04%17,138
4Institution<0.01%13

FAQ

Who Owns Arca Biopharma (ABIO)?
Currently, no data Available
What percentage of Arca Biopharma (ABIO) stock is held by institutional investors?
Currently, no data Available
What percentage of Arca Biopharma (ABIO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Arca Biopharma (ABIO)?
Krishna Kittu Kolluri owns the most shares of Arca Biopharma (ABIO).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis